Form 8-K - Current report:
SEC Accession No. 0001558370-22-018607
Filing Date
2022-12-13
Accepted
2022-12-13 17:07:24
Documents
17
Period of Report
2022-12-12
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20221212x8k.htm   iXBRL 8-K 43811
2 EX-16.1 aytu-20221212xex16d1.htm EX-16.1 6403
3 GRAPHIC aytu-20221212xex16d1001.jpg GRAPHIC 4357
4 GRAPHIC aytu-20221212xex16d1003.jpg GRAPHIC 4992
5 GRAPHIC aytu-20221212xex16d1004.jpg GRAPHIC 3373
6 GRAPHIC aytu-20221212xex16d1002.jpg GRAPHIC 4368
  Complete submission text file 0001558370-22-018607.txt   197429

Data Files

Seq Description Document Type Size
7 EX-101.SCH aytu-20221212.xsd EX-101.SCH 3131
8 EX-101.LAB aytu-20221212_lab.xml EX-101.LAB 15903
9 EX-101.PRE aytu-20221212_pre.xml EX-101.PRE 10060
11 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20221212x8k_htm.xml XML 4914
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

EIN.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 221460384
SIC: 2834 Pharmaceutical Preparations